Comité de Honor 

Comité Científico  

Comité Técnico 

Registrarse

Programa  

Comunicaciones

Instrucciones para el IRC (chat)

BIBLIOGRAFÍA

1. Guidelines. Acute myocardial infarction: pre-hospital and in-hospital management. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart Journal 1996; 17: 43-63.

2. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-428.

3. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico). Effectiveness of intravenous thrombolytic treatment in acute miocardial infarction. Lancet 1986; 1:397-401.

4. ISAM (Intravenous Streptokinase in Acute Myocardial Infarction) Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity and infarct size at 21 days. N Engl J Med 1986; 314: 1.465-71.

5. AIMS (APSAC Intervention Mortality Study) Trial Study Group. Effects of intravenous APSAC on mortality after acute miocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988; 1: 545-9.

6. ISIS-2 (Second International Study of Infartc survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, borh, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-60.

7. Wilcox RJ, Von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR for the ASSET (Anglo-Scandinavian Study of Early Thrombolysis) Study Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction (ASSET). Lancet 1988; 2: 525-30.

8. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41299 cases of suspected acute miocardial infarction. Lancet 1992; 339: 753-70.

9. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group. Randomised trial of late thrombolysis in patients with suspected acute miocardial infarction. Lancet 1993; 342: 767-72.

10. LATE Study Group. Late Assessment of Thrombolitic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute miocardial infarction. Lancet 1993; 342: 759-66.

11. Pfeffer MA, Moye LA, Braunwald E. et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA 1991; 266: 528-32.

12. The Thrombolysis Early in Acute Heart Attack Trial Study Group. Very early thrombolitic therapy in suspected acute miocardial infarction. Am J Cardiol 1990; 65: 401-7.

13. The International Study Group. In-hospital mortality and clinical course of 20981 patients with suspected acute miocardial infarction randomized between alteplase and streptokinase with or without heparin. Lancet 1990; 336: 71-5

14. Fibrinolytic Therapy Trialist' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute miocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.

15. Meischke H et al. : Call fast, Call 911:  A direct mail campaign to reduce patient delay in acute myocardial infraction. Am J Public Health 1997; 87: 1705-1709.

16. Birkehead, JS (1992) Time delays in provision of thrombolytic treatment in six district hospital. BMJ, 305, 445-8.

17. Kereiakis DJ, Weaver WD, Anderson JL, et. Al. (1990) Time delays in teh diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Am. Heart J,120, 773-9.

18. ACC/AHA Task Force Report. Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutics cardiovascular procedures (Subcommittee to develop Guidelines For the Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol 1990; 16: 249-292.

19. Anderson HV, Willerson JT. Thrombolysis in acute miocardyal infarction. N Engl J Med 1993; 329: 703-9.

20. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary patency, ventricular function, and survival after acute miocardial infarction. N Engl J Med 1993; 329: 1.615-22.

21. Leebow W, Ersoz CJ: The health care manager´s guide to continuous quiality improvement. AHA, Chicago 1991, Chapter 11, 143-187.

22. Kume H: Statistical methods for Quality Improvement. AOTS, Tokyo, 1992. Chapter 3, 17-24. 23. Farnum NR: Modern Statistical Quality  Control and Improvemnt. Duxbury Press, Belmont, 1994, ch. 6, 171-175.

24. Anonymous. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction. The Continuous infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators. N Engl J Med 1997; 337: 1124-30.

25. Mathey DG, Sheehan F, Schofer J, Dodge HT. Time from onset of symtoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. J Am Coll Cardiol 1985; 6: 518-25.

26. Porter G, Doughty R, Gamble J, Sharpe N. Thrombolysis in acute myocardial infarction: reducing in hospital treatment delay. N Z Med J 1995; 108: 253-54.

27. Birkhead JS on behalf of the joint audit committee of the British Cardiac Society and a cariology committee of Royal College of Physicians of London. Time delays in provision of thrombolytic treatment in six district hospitals. Br Med J 1992; 305: 445-48.

28. Pell ACH, Miller HC, Robertson CE, Fox KAA. Effect of "fast track" admission for acute myocardial infarction on delay to thombolysis. Br Med J 1992; 304: 83-87.0. 29.

29. Saturno P, Felices F, Segura J, Vera A, Rodríguez JJ. Reducing time delay in the thrombolysis of miocardial infarction: An internal quality improvement project. American Journal Medical Quality 2000; 15:85-93.

(Volver)